Skip to Content Skip to Content

Cancer Research

Four Penn faculty elected to the National Academy of Sciences
head shots of Marisa Bartolomei, M. Celeste Simon, Michael Kearns, and Diana Mutz

Four Penn faculty elected to the National Academy of Sciences

The new members of the Academy, honored scholars recognized for their unique and ongoing contributions to original research, include researchers from the Perelman School of Medicine, School of Engineering and Applied Science, and Annenberg School for Communication.

Erica K. Brockmeier

Cancer cell therapy pioneer Carl June receives the Sanford Lorraine Cross Award
carl june

Cancer cell therapy pioneer Carl June receives the Sanford Lorraine Cross Award

The Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine and director of the Center for Cellular Immunotherapies at Penn’s Abramson Cancer Center received the award for his work in developing chimeric antigen receptor (CAR) T cell therapy.

Steve Graff

Take-at-home tests boost colorectal cancer screening tenfold
Four empty vials for human stool samples.

Take-at-home tests boost colorectal cancer screening tenfold

By making it the default to send screening tests to patients’ homes unless they opted out via text message, screening rates increased by more than 1000%.

From Penn Medicine News

Patients in cancer remission at high risk for severe COVID-19 illness
African American person wearing a face mask having their temperature taken via forehead scanner by a masked, gloved medical professional.

Patients in cancer remission at high risk for severe COVID-19 illness

Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, with Black cancer patients twice as likely to test positive for the virus.

Steve Graff

Mutations commonly linked to breast cancer found to pose no increased risk
Gloved hands putting individual tiny pipettes in a holder in a lab setting.

Mutations commonly linked to breast cancer found to pose no increased risk

Several genetic mutations previously linked to breast cancer and included on commercial genetic tests were found not to increase a woman’s risk of disease, according to a multi-institutional population study of more than 64,000 women.

Steve Graff